Last reviewed · How we verify
NCT03821285
Respiratory Function in Patients With Post-tuberculosis Lung Impairment
NA trial testing Pulmonary Rehabilitation in Lung Diseases, Obstructive in 100 participants. Status unknown.
31 July 2020
Quick facts
| Lead sponsor | Università degli Studi dell'Insubria |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | screening |
| Enrollment | 100 |
| Start date | 14 February 2019 |
| Primary completion | 31 July 2020 |
| Estimated completion | 14 January 2021 |
| Sites | 1 location across Italy |
Drugs / interventions tested
- Pulmonary Rehabilitation
Conditions studied
- Lung Diseases, Obstructive — all drugs for Lung Diseases, Obstructive →
- Pulmonary Rehabilitation — all drugs for Pulmonary Rehabilitation →
- Lung TB — all drugs for Lung TB →
Sponsor
Università degli Studi dell'Insubria — full company profile →
Who can join
Eligibility, any sex, with Lung Diseases, Obstructive or Pulmonary Rehabilitation. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Pulmonary tuberculosis (TB) is an important risk factor for chronic respiratory disease due to residual lung damage. A recent review of the literature on TB sequelae and rehabilitation has provided clear evidence that TB is definitively responsible for lung function impairment. Functional evaluation of TB patients after completion of pulmonary tuberculosis treatment or spontaneous healing should be considered as part of clinical care. Unfortunately, few studies are available in the literature investigating the physiopathology of lung damage, its impact on quality of life, the potential need for pulmonary rehabilitation (PR), and the effects of a PR program.Objectives of this prospective multicentre international study are: Primary Objective-to assess the exercise capacity 6-min walking test in patients with post-TB lung impairment after completion of pulmonary tuberculosis treatment or after spontaneous healing. Secondary Objectives-to assess the effects of the PR program on dyspnoea symptoms and muscle fatigue, quality of life.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT03821285
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Pulmonary Rehabilitation
Trials testing the same drug.
- NCT07197229 — Hospital- and Home-Based Structured Pulmonary Rehabilitation in Recently Admitted COPD Patients: A Quasi-Experimental St · NA · not yet recruiting
- NCT07376161 — Inflammation and Oxidative Stress in COPD · enrolling by invitation
- NCT07097961 — Paediatric Post-TB Pulmonary Rehab Study · NA · recruiting
- NCT06756230 — Downhill Walking in IPF · NA · recruiting
- NCT06707623 — CPET Guided Rehab vs Physiotherapy in Patients With Dysfunctional Breathing · NA · recruiting
Other recruiting trials for Lung Diseases, Obstructive
Currently open trials in the same condition.
- NCT05940480 — TCM Daoyin Therapy in Individuals At-risk for COPD · NA · active not recruiting
Other Università degli Studi dell'Insubria trials
Trials by the same sponsor.
- NCT03440086 — Temporary Application of Abdominal Jackson-Pratt Drain to Reduce Pain After Laparoscopic Surgery in Gynecology · NA · not yet recruiting
- NCT06628999 — Perceptual-vision Training and Intellectual Disabilities · NA · not yet recruiting
- NCT06989554 — Tactile Incentiviser Improves Partial Weight Bearing After Lower-Limb Surgery · NA · completed
- NCT05436899 — A Pilot Study on Training Simulator Efficacy · NA · unknown
- NCT03442491 — Hayman's Haemostatic Suture to Treat Severe Post-partum Haemorrhage · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03821285 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Università degli Studi dell'Insubria
- Last refreshed: 29 January 2019
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03821285.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing